Advertisement
Screener

Quince Therapeutics, Inc. (QNCX) Cash Flow Breakdown

Quince Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Quince Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $41.42M went out.
  • Fiscal year ended 2025-12-31: from investing, $23.23M came in.
  • Fiscal year ended 2025-12-31: from financing, $17.91M came in.
  • Fiscal year ended 2025-12-31: change in cash, $403.00K went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$41.42M$23.23M$220.00K$17.69M*-$403.00K
2024-12-31-$31.90M$21.91M$225.00K-$5.00M*-$14.54M
2023-12-31-$18.29M-$5.76M$149.00K-$23.83M
2022-12-31-$44.04M$18.00M$608.00K-$25.14M
2021-12-31-$62.93M$58.95M$0.00$6.81M*$2.88M
2020-12-31-$50.82M-$52.43M$1.28M$117.59M*$15.63M
2019-12-31-$33.28M-$17.75M$97.00K$77.27M*$26.34M
2018-12-31-$11.70M-$46.75M$24.00K$75.90M*$17.48M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$18.89M*$8.00M*$0.00*$108.93M*
2026-03-31-$7.63M$12.00M$0.00$9.44M*$12.35M
2025-12-31-$10.48M*$8.07M*$37.00K*$2.00M*
2025-09-30-$9.93M*-$1.78M*$0.00*$1.38M*
2025-06-30-$11.41M*$6.04M*$96.00K*$14.32M*
2025-03-31-$9.60M$10.90M$87.00K$1.56M
2024-12-31-$7.55M*$10.87M*$0.00*
2024-09-30-$7.26M*$7.11M*$0.00*-$5.00M*
2024-06-30-$8.74M*-$4.98M*$35.00K*
2024-03-31-$8.35M$8.91M$190.00K$1.06M
2023-12-31-$6.08M*$5.39M*$57.00K*
2023-09-30-$4.82M*$3.63M*$10.00K*
2023-06-30-$3.83M*-$20.32M*$26.00K*
2023-03-31-$3.57M$5.54M$56.00K$2.13M
2022-12-31-$5.83M*$18.67M*$0.00*
2022-09-30-$6.70M*-$8.83M*$0.00*
2022-06-30-$15.41M*-$5.25M*$0.00*
2022-03-31-$16.09M$13.41M$608.00K-$2.16M
2021-12-31-$14.42M*$20.92M*$0.00*$990.00K*
2021-09-30-$17.34M*$766.00K*$0.00*$4.71M*
2021-06-30-$17.56M*$5.62M*$0.00*$672.00K*
2021-03-31-$13.61M$31.64M$0.00$18.47M
2020-12-31-$13.28M*$15.83M*$47.00K*
2020-09-30-$12.37M*$10.37M*$90.00K*
2020-06-30-$14.39M*-$5.95M*$954.00K*
2020-03-31-$10.78M-$72.68M$191.00K$117.66M*$34.39M
2019-12-31-$10.95M*$17.70M*$28.00K*-$558.00K*
2019-09-30-$8.80M*$9.22M*$0.00*
2019-06-30-$6.32M*-$47.84M*$5.00K*$77.83M*
2019-03-31-$7.22M$3.16M$64.00K-$3.99M
2018-12-31-$3.97M*$1.56M*
2018-09-30-$1.93M*-$48.30M*
2018-06-30-$2.62M*$75.70M*
2018-03-31-$3.18M-$2.94M

Similar stocks

Stock NameCountryMarket CapPE Ratio
CEL SCI CORP (CVM)United States$0.030B-0.81
aTYR PHARMA INC (ATYR)United States$0.033B-0.98
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
Scilex Holding Co (SCLX)United States$0.042B-0.14
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioCardia, Inc. (BCDA)United States$0.016B
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
LeonaBio, Inc. (LONA)United States$0.047B-0.61